MoneyWorks4Me

Mercury Laboratories - Quaterly Results

21 Oct 2021 Evaluate
The sales slipped to Rs. 134.73 millions for the September 2021 quarter as against Rs. 189.10 millions during the year-ago period.Net Profit of the company move down -41.75% to Rs. 9.64  millions from Rs. 16.55 millions  in the same quarter last year.Operating profit for the quarter ended September 2021 decreased to 22.56 millions as compared to 30.87 millions of corresponding quarter ended September 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 134.73 189.10 -28.75 289.96 322.64 -10.13 686.02 572.69 19.79
Other Income 2.35 3.60 -34.72 3.64 3.91 -6.91 8.80 8.50 3.53
PBIDT 22.56 30.87 -26.92 46.68 50.14 -6.90 104.72 70.16 49.26
Interest 1.43 2.73 -47.62 2.53 3.96 -36.11 6.41 8.18 -21.64
PBDT 21.13 28.14 -24.91 44.15 46.18 -4.40 98.31 61.98 58.62
Depreciation 7.03 5.19 35.45 12.13 9.66 25.57 19.21 18.69 2.78
PBT 14.10 22.95 -38.56 32.02 36.52 -12.32 79.10 43.29 82.72
TAX 4.46 6.40 -30.31 9.92 10.37 -4.34 25.72 11.01 133.61
Deferred Tax 0.55 0.86 -36.05 1.17 2.41 -51.45 3.88 -0.82 -573.17
PAT 9.64 16.55 -41.75 22.10 26.15 -15.49 53.38 32.28 65.37
Equity 12.00 12.00 0.00 12.00 12.00 0.00 12.00 12.00 0.00
PBIDTM(%) 16.74 16.32 2.57 16.10 15.54 3.59 15.26 12.25 24.60
Peers
Company Name CMP
Sun Pharma. Inds. 1840.55
Dr. Reddys Labs. 1245.45
Cipla 1387.80
Lupin 2075.00
Zydus Lifesciences 1212.35
View more..